BioSpace News Archive

Pharm Country

NRx Pharmaceuticals Notes New Data on BriLife® COVID-19 Vaccine Effectiveness Against Delta Variant Posted by Israel Institute for Biological Research

NRx Pharmaceuticals, notes that the Israel Institute for Biological Research has posted scientific results from an initial sample of phase 2 vaccinated patients in order to assess the potential effectiveness of the BriLife® vaccine against the Delta variant of the SARS-CoV-2 virus.

November 26, 2021
·
5 min read
Genetown

Moderna Announces Strategy to Address Omicron (B.1.1.529) SARS-CoV-2 Variant

Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, announced updates to its strategy to address SARS-CoV-2 variants of concern, given the emergence of the B.1.1.529 variant.

November 26, 2021
·
6 min read
Business

AnPac Bio Reports Nine Months Ended September 30, 2021, Same Period Achieved Record Revenue Increased By 55.3% While Non-GAAP Net Loss Reduced by 6.8%

AnPac Bio-Medical Science Co., Ltd., a biotechnology company with operations in China and the United States, announced its unaudited financial results for the nine months ended September 30, 2021.

November 26, 2021
·
16 min read